Lasa Supergenerics Limited Stock Return On Asset
| LASA Stock | 26.58 1.26 4.53% |
Lasa Supergenerics Limited fundamentals help investors to digest information that contributes to Lasa Supergenerics' financial success or failures. It also enables traders to predict the movement of Lasa Stock. The fundamental analysis module provides a way to measure Lasa Supergenerics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lasa Supergenerics stock.
Lasa | Return On Asset |
Lasa Supergenerics Limited Company Return On Asset Analysis
Lasa Supergenerics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Lasa Supergenerics Return On Asset | -0.0338 |
Most of Lasa Supergenerics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lasa Supergenerics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Lasa Total Assets
Total Assets |
|
Based on the latest financial disclosure, Lasa Supergenerics Limited has a Return On Asset of -0.0338. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all India stocks is notably higher than that of the company.
Lasa Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lasa Supergenerics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lasa Supergenerics could also be used in its relative valuation, which is a method of valuing Lasa Supergenerics by comparing valuation metrics of similar companies.Lasa Supergenerics is currently under evaluation in return on asset category among its peers.
Lasa Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0338 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 1.58 B | ||||
| Shares Outstanding | 50.1 M | ||||
| Shares Owned By Insiders | 62.70 % | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 1.34 X | ||||
| Revenue | 1.04 B | ||||
| Gross Profit | 220.46 M | ||||
| EBITDA | (65.08 M) | ||||
| Net Income | (217.31 M) | ||||
| Cash And Equivalents | 15.91 M | ||||
| Total Debt | 220.76 M | ||||
| Book Value Per Share | 19.30 X | ||||
| Cash Flow From Operations | 21.38 M | ||||
| Earnings Per Share | (4.54) X | ||||
| Number Of Employees | 77 | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 1.41 B | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | (469.78 M) | ||||
| Working Capital | (109.81 M) | ||||
| Net Asset | 1.51 B |
About Lasa Supergenerics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lasa Supergenerics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lasa Supergenerics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lasa Supergenerics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lasa Stock Analysis
When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.